David L. Herzog - Mar 11, 2025 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Taylor Jansen, Authorized Signer
Stock symbol
MET
Transactions as of
Mar 11, 2025
Transactions value $
$3,609
Form type
4
Date filed
3/13/2025, 04:18 PM
Previous filing
Jan 6, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $3.61K +46 +0.18% $78.45 25.9K Mar 11, 2025 Direct F1
holding MET Common Stock 87 Mar 11, 2025 by David L. Herzog Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.